6
Oct
2026
CTX Lifesciences
Exhibitor at CPHI Milan 2026 stand 4A87, API
About Us
Categories
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:4
-
Employees:500 - 999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 4A87, API
Products Featured at CPHI Milan 2026
-
Product Brexpiprazole
Brexpiprazole API is a medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. It is an atypical antipsychotic. -
Product Saxagliptin
Saxagliptin is used along with diet and exercise to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Saxagliptin is in a class of medications called dipeptidyl peptidase-4 (dpp-4) inhibitors. -
Product Vildagliptin
Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of Glucagon-like peptide-1(GLP-1) and Glucose-dependent insulinotropic polypeptide(GIP) by DPP-4, allowing GLP-1 and GIP to potentiat... -
Product Hydrochlorothiazide
Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxidesubstituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, ... -
Product Oxcarbazepine
Oxcarbazepine is a keto analogue of Carbamazepine and, like the parent drug, is a potent anticonvulsant used alone or in combination with other agents in the therapy of poartial seizures. Oxcarbazepine is a dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepi...
CTX LifeSciences Pvt. Ltd. Resources (1)
-
Video CTX Lifesciences - Your Preferred API, Intermediates Manufacturing & CDMO Partner from India.
CTX Lifesciences, a vertically integrated Active Pharmaceutical Ingredient (API ) and intermediates manufacturing company supplying & exporting its products across 87 countries. It was established in the year of 2004 in Surat, India and is a part of family owned $600 Million group. This Facility is having over 1000 KL reaction volume and is spread across 38 acres land with sufficient area for expansion. The Active Pharmaceutical Ingredient (API ) products manufactured are backward integrated into intermediates and Key Starting Materials( KSM ), allowing better controls on quality of the products and supply reliability for our customers. This facility is compliant and approved by USFDA, EUGMP, Health Canada, ANVISA, RUGMP, KFDA, COFEPRIS & Iran MOH. The facility is having excellent EHS Management capabilities and certified with ISO 14001:2015 , ISO 45001:2018. This facility is also Ecovadis Rated and Pharmaceutical Supply Chain Initiative ( PSCI ) Audited. Driven...




